The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global pharmaceutical contract packaging market size reached US$ 18.44 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 29.62 Billion by 2027, exhibiting at a CAGR of 8.07% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Drugs need to be packed safely after production to offer optimum pharmacological effects to patients. As a result, pharmaceutical companies worldwide resort to outsourcing of secondary operations, which include labeling and packaging of drugs, to contract firms. These firms also provide secondary services, such as assembling and secondary packaging of vials, auto-injectors, and prefilled syringes. As pharmaceutical contract packaging is relatively flexible, profitable, and helps keep up with the dynamic market scenario, its demand is escalating worldwide.
The lack of expertise, budget constraints, and in-house packaging capabilities are major issues encountered by small pharmaceutical companies in the industry. As a result, there is a rise in the demand for pharmaceutical contract packaging services across the globe. Pharmaceutical contract packaging vendors can undertake several types of packaging projects and easily sort issues arising from complex packaging requirements. These vendors are also investing in research and development activities to enhance the quality of their offerings. In addition, contract packaging service providers are making considerable attempts to offer highly sophisticated packaging facilities and meet the expectations of their clients. Apart from this, the implementation of stringent rules and regulations by the governing authorities of numerous countries regarding the packaging of drugs acts as another growth-inducing factor of the market. Furthermore, the increasing utilization of smart packaging solutions, such as smart labels, is projected to strengthen the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical contract packaging market report, along with forecasts for growth at the global and regional level from 2022-2027. Our report has categorized the market based on industry, type and packaging.
Breakup by Industry:
Breakup by Type:
Sterile pharmaceutical contract packaging holds the largest market share on account of the stringent standards set by hospital authorities worldwide to prevent the transmission of different diseases.
Breakup by Packaging:
Plastic bottles dominate the market as they are lightweight, convenient, re-sealable and safe from shattering, unlike glass bottles.
Breakup by Region:
At present, the United States enjoys the leading position in the market due to the quality service offerings in the country.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry.
|Base Year of the Analysis||2021|
|Segment Coverage||Industry, Type, Packaging, Region|
|Region Covered||United States, Europe, China, India, Others|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at